Tuesday, March 21, 2017 9:25:43 PM
FDA wants to know the product is safe. USRM uses a persons own stem cells for treatment. The company claims greater than 99% safety. Once safety is relatively determined, they want to know that the product shows statistically significant improvement in the patient's well being or health. USRM has claimed that there are stat sig. positive results. Finally, the FDA chair is a supporter of stem cell treatments as he has stated as much on the record. With this in mind, the only reason I see for denying FDA approval would be undue influence from a competitor - politics.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM